Galmed Pharmaceuticals Ltd. buy BTIG Research
Start price
08.05.24
/
50%
€0.36
Target price
08.05.25
€58.61
Performance (%)
1667.96%
End price
09.05.25
-
Summary
This prediction is currently being closed. With a performance of 1667.96% the BUY prediction by BTIG_Research is a big success. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | 0.224% | 1.487% | 3.575% |
| iShares Nasdaq 100 | 6.047% | 16.188% | 39.144% |
| iShares Nikkei 225® | 5.724% | 11.690% | 50.962% |
| iShares S&P 500 | 2.172% | 8.056% | 25.618% |
Comments by BTIG_Research for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at BTIG Research from $60.00 to $63.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten
Stopped prediction by BTIG_Research for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
12.12.24
12.12.24
€86.70
12.12.25
12.12.25
-
13.12.25
13.12.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
14.10.24
14.10.24
€71.53
14.10.25
14.10.25
-
15.10.25
15.10.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.24
28.08.24
28.08.24
€69.28
28.08.25
28.08.25
2589.08%
29.08.25
29.08.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.27
16.07.24
16.07.24
€68.81
16.07.25
16.07.25
-15.56%
17.07.25
17.07.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.33
29.05.24
29.05.24
€66.36
29.05.25
29.05.25
1827.71%
30.05.25
30.05.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.30
18.03.24
18.03.24
€55.09
18.03.25
18.03.25
2062.16%
19.03.25
19.03.25